Rybelsus is an FDA-approved swallowed semaglutide tablet manufactured by Novo Nordisk and absorbed through the GI tract
Side effect comparison The side effect comparison between semaglutide and tirzepatide shows that GI side effects are a class effect of GLP-1 agonism
This is achieved by giving extra insulin, carbohydrates to stop low blood sugars from the insulin injections and fluids to flush the ketones produced from fat breakdown out of the body
Because obesity treatment is multimodal, it is essential to adhere to a healthy diet and exercise regularly to get the desired results
A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
I will always choose semaglutide [Ozempic] for weight loss over dulaglutide [Trulicity], if access and cost are equal, Dr